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BACKGROUND: There are no clinical guidelines on best practices for the use of bronchoscopy and esophagoscopy in diagnosing
head and neck cancer. This retrospective cohort study examined variation in the use of bronchoscopy and esophagoscopy across
hospitals in Michigan. METHODS: A total of 17,828 patients were identified with head and neck cancer in the 2006 to 2010 Michigan
State Ambulatory Surgery Databases. A hierarchical, mixed-effect logistic regression was used to examine whether a hospital’s risk-
adjusted rate of concurrent bronchoscopy or esophagoscopy was associated with its case volume (< 100, 100-999, or 1000 cases
per hospital) for those undergoing diagnostic laryngoscopy. RESULTS: Of 9218 patients undergoing diagnostic laryngoscopy, 1191
(12.9%) received concurrent bronchoscopy and 1675 (18.2%) underwent concurrent esophagoscopy. The median hospital rate of bron-
choscopy was 2.7% (range, 0%-61.1%), and low-volume (odds ratio [OR]527.1; 95% confidence interval [CI]5 1.9, 390.7) and medium-
volume (OR528.1; 95% CI52.0, 399.0) hospitals were more likely to perform concurrent bronchoscopy compared to high-volume
hospitals. The median hospital rate of esophagoscopy was 5.1% (range, 0%-47.1%), and low-volume (OR59.8; 95% CI5 1.5, 63.7) and
medium-volume (OR58.5; 95% CI5 1.3, 55.0) hospitals were significantly more likely to perform concurrent esophagoscopy relative
to high-volume hospitals. CONCLUSIONS: Patients with head and neck cancer who are undergoing diagnostic laryngoscopy are
much more likely to undergo concurrent bronchoscopy and esophagoscopy at low- and medium-volume hospitals than at high-
volume hospitals. Whether this represents overuse of concurrent procedures or appropriate care that leads to earlier diagnosis and
better outcomes merits further investigation. Cancer 2014;120:61-7. VC 2013 American Cancer Society.
KEYWORDS: otolaryngology, endoscopy, head and neck cancer, diagnostic techniques and procedures, hospital volume, Michigan
State Ambulatory Surgery Databases, Michigan.
INTRODUCTION
The National Institutes of Health (NIH) estimated that the costs of cancer in 2008 were $201.5 billion, attributed to both
direct medical costs and indirect costs such as lost productivity due to premature death.1 In the increasingly cost-conscious
US health care system, there is concern that variation in cancer-related costs is being driven by expensive diagnostic and
therapeutic technologies, differences in reimbursement strategies, and physician-induced demand.2-5
Diagnostic practice patterns in head and neck cancer (HNC) are poorly understood. In the only study to date on var-
iation in diagnostic upper aero-digestive tract (UADT) endoscopy, Deleyiannis et al6 examined a cohort of 1140 patients
with HNC from the Surveillance, Epidemiology, and End Results (SEER) Program and Medicare claims databases from
1991 to 1993. The authors found that across 5 SEER sites (Connecticut; Detroit, Michigan; Iowa; San Francisco, Califor-
nia; Seattle, Washington), bronchoscopy usage ranged from 6.9% to 32.7% for local cancer and 12.8% to 50.7% for re-
gional cancer, whereas esophagoscopy usage ranged from 12.9% to 39.8% for local cancer and 22.2% to 59.7% for
regional cancer. SEER geographic area was found to be associated with the degree of both esophagoscopy and bronchos-
copy use even after controlling for differences in age, sex, race, tumor site and grade, Charlson comorbidity index, and
socioeconomic status.
Corresponding author: Gordon H. Sun, MD, MS, Partnership for Health Analytic Research, LLC, 280 South Beverly Drive, Suite 404 Beverly Hills, CA 90212, Fax:
(310) 858-9552 gsun@pharllc.com
1Partnership for Health Analytic Research, LLC, Beverly Hills, California; 2Robert Wood Johnson Foundation Clinical Scholars, University of Michigan, Ann Arbor,
Michigan; 3Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan; 4VA Center for Clinical Management Research,
Ann Arbor VA Healthcare System, Ann Arbor, Michigan; 5Section of Plastic Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan; 6Depart-
ment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania; 7Department of Neurology, University of Michigan, Ann Arbor, Michigan
This study was presented as a poster at the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, on June 1, 2013.
DOI: 10.1002/cncr.28379, Received: July 25, 2013; Revised: August 27, 2013; Accepted: August 29, 2013, Published online September 24, 2013 in Wiley Online
Library (wileyonlinelibrary.com)
Cancer January 1, 2014 61
Original Article
Current published clinical guidelines from the
National Comprehensive Cancer Network (NCCN) are
generally ambiguous in regard to optimal UADT endo-
scopic evaluation. The lack of clear clinical guidelines
itself may be due to a paucity of relevant high-quality
research. There is currently no evidence that routine com-
prehensive UADT endoscopy (“panendoscopy”), com-
pared to selective symptom-directed endoscopy, confers a
high yield or added survival benefit to patients with
HNC.7 The proliferation of advanced, less invasive diag-
nostic modalities such as computed tomography (CT)
and barium esophagography has complicated the choice
of modality to evaluate the tracheobronchial tree and
esophagus, if they are performed at all.
In this study, we revisited the problem of variation
in diagnostic UADT endoscopy for patients with HNC at
the hospital level. We sought to examine how often bron-
choscopy and esophagoscopy were used in conjunction
with laryngoscopy in the diagnostic evaluation of patients
with HNC, and whether this practice varied significantly
between hospitals with lower versus higher case volumes.
MATERIALS AND METHODS
We conducted a retrospective cohort analysis of the 2006
to 2010 Healthcare Cost and Utilization Project (HCUP)
Michigan State Ambulatory Surgery Databases (SASD),
sponsored by the Agency for Healthcare Research and
Quality. The Michigan SASD is an all-payer database
containing discharge data for 100% of the ambulatory
procedures performed at hospital-based ambulatory sur-
gery, rehabilitation, and osteopathic centers.8,9 We used
publicly available, de-identified Michigan SASD data and
received an exemption from the University of Michigan
Medical School Institutional Review Board.
First, we identified patients with a diagnosis of ma-
lignant neoplasms of the head and neck, using Interna-
tional Classification of Diseases, Ninth Revision with
Clinical Modification (ICD-9-CM) diagnostic codes 140-
149 and 161. We initially determined whether HNC
patients underwent laryngoscopy using Current Proce-
dural Terminology (CPT) codes 31510, 31512, 31515,
31525, 31526, 31535, 31526, 31535, 31536, 31540,
31541, 31575, 31576, and 31578. All analyses were based
on this subgroup of patients with HNC, because the lar-
yngoscopy is the core procedure around which other
aspects of diagnostic UADT evaluation are based. We also
identified patients who underwent bronchoscopy (CPT
31615, 31622, 31623, 31624, 31625, 31640, and
31461), virtual bronchoscopy (CPT 31626 and 31627),
esophagoscopy (CPT 43200, 43202, 43217, 43235, and
43239), and esophageal radiographic studies (CPT
74220, 74230, 74240, 74241, 74245, 74246, 74247, and
74249).
We excluded records missing hospital identifier or
ZIP code data (n5 1159), as well as cases done in hospi-
tals that had fewer than 10 patients with a diagnosis of
HNC per year of study (n5 141). The primary unit of
analysis was defined as hospital case volume, stratified by
orders of magnitude into low-, medium-, and high-
volume centers (99 or fewer, 100 to 999, and 1000 or
more operative HNC patients annually per hospital,
respectively). We selected hospital volume for study
because this characteristic has been used to show signifi-
cant disparities in both access and patient outcomes for
select major oncologic procedures.10-12 As a sensitivity
analysis, we examined a subset of patients who lived in the
same Michigan hospital service areas (HSAs) where they
were treated. HSAs are described by the Dartmouth Atlas
of Health Care as local health care markets for hospital-
based care, defined as a collection of ZIP codes whose resi-
dents are hospitalized primarily in hospitals in that area.
HSA data were acquired for the patients in our study by
merging the SASD databases for each year of study with
corresponding Dartmouth Atlas HSA crosswalk data
sets.13 An additional 349 patients were excluded from this
subgroup analysis.
We used Stata version 12.1 (StataCorp LP, College
Station, Tex) for all analyses. We constructed hierarchical,
mixed-effect logistic regression models using maximum
likelihood estimation to calculate the odds that a patient
with HNC who underwent laryngoscopy also underwent
either bronchoscopy or esophagoscopy. We also calcu-
lated intraclass correlation coefficients (ICCs), which
were used to determine the proportion of variation in
bronchoscopy or esophagoscopy rate between hospitals at-
tributable to hospital HNC case volume.14 We controlled
for the potential confounding variables patient age, sex,
and urban/rural place of residence as fixed effects. Hospi-
tal case volume was included as a random effect. Patients
were clustered by hospital and HSA in separate 2-level
analyses.
RESULTS
After excluding cases missing hospital identifier or ZIP
code data and cases from hospitals performing laryngos-
copies on fewer than 10HNC patients per year, we identi-
fied 17,828 HNC cases in 92 hospitals, 9218 (52%) of
whom underwent diagnostic laryngoscopy. Patient and
hospital characteristics are listed in Table 1. Of those
undergoing laryngoscopy, 1191 (12.9%) patients
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underwent concurrent bronchoscopy and 1675 (18.2%)
underwent concurrent esophagoscopy. The median hos-
pital rate of concurrent bronchoscopy was 2.7% (range,
0%-61.1%), and 26 (28.3%) of the 92 hospitals in the
study did not perform any concurrent bronchoscopies
(Fig. 1). The median hospital rate of concurrent esopha-
goscopy was 5.1% (range, 0%-47.1%), and 14 (15.2%)
hospitals performed no concurrent esophagoscopies (Fig.
2). No hospital reported doing any virtual bronchoscop-
ies, whereas only 30 (0.3%) cases included esophageal ra-
diographic studies.
In unadjusted analyses, concurrent bronchoscopy
and esophagoscopy were significantly more common at
hospital with low or moderate HNC case volumes than at
high-volume hospitals (Table 2). Empty hierarchical
regression modeling demonstrated a significant associa-
tion between bronchoscopy and hospital case volume
(P< .001). After controlling for age, sex, and area of resi-
dence, the regression model remained statistically signifi-
cant (P< .001) with an ICC of 0.511. The model was
statistically significant (P< .001) and the ICC was 0.506
after controlling for hospital HNC case volume. Thus,
approximately 0.9% of overall variation in bronchoscopy
rate was due to hospital case volume. Low-volume hospi-
tals had an adjusted odds ratio (OR) of 27.1 (95% confi-
dence interval [CI]5 1.9, 390.7) of performing
concurrent bronchoscopy compared to high-volume hos-
pitals, whereas medium-volume hospitals had an adjusted
OR of 28.1 (95%CI5 2.0, 399.0).
The association between esophagoscopy and hospi-
tal case volume was not statistically significant in the
TABLE 1. Characteristics of Head and Neck Cancer
Patients in Michigan Undergoing Outpatient
Diagnostic Laryngoscopy in 2006-2010 (n59218)
Patient or Hospital Characteristic Value
Age (mean6 standard deviation) 61.9611.5 y
Male sex 75.7%
White race 82.3%
Insurance status
Public/government 55.0%
Private 42.5%
Other 2.5%
Urban residence 77.0%
Median household income
1st quartile 27.2%
2nd quartile 26.1%
3rd quartile 23.8%
4th quartile 22.9%
Hospital case volume
Low (<100 cases) 6.9%
Medium (100-999 cases) 38.5%
High (10001 cases) 54.6%
Figure 1. Hospital rates of concurrent bronchoscopy are show, based on all head and neck cancer diagnostic laryngoscopy cases
in Michigan performed from 2006 to 2010. The red line represents the median rate of hospital bronchoscopy (2.7%).
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empty hierarchical model (P5 .054). However, after con-
trolling for patient-level characteristics, the model
achieved statistical significance (P5 .004) and an ICC of
0.344. The model remained statistically significant
(P5 .002) with an ICC of 0.335 after including HNC
case volume at the hospital level. Thus, approximately
2.7% of overall variation in esophagoscopy rate was attrib-
utable to hospital case volume. Compared to high-volume
hospitals, low-volume hospitals had an adjusted OR of
9.8 (95% CI5 1.5, 63.7) of performing concurrent
esophagoscopy, whereas medium-volume hospitals dem-
onstrated an adjusted OR of 8.5 (95% CI5 1.3, 55.0).
Sensitivity analyses using hospital volume tertiles, rather
than our a priori high/medium/low categories, revealed
similar findings for both bronchoscopy and
esophagoscopy.
DISCUSSION
Our study demonstrated large differences in the use of
concurrent bronchoscopy and esophagoscopy across
Michigan hospitals based on the number of operative
HNC patients treated in each institution annually.
Figure 2. Hospital rates of concurrent esophagoscopy are shown, based on all head and neck cancer diagnostic laryngoscopy
cases in Michigan performed from 2006 to 2010. The red line represents the median rate of hospital esophagoscopy (5.1%).
TABLE 2. Percentage of Laryngoscopy Patients Who Also Underwent Concurrent Bronchoscopy or
Esophagoscopy
Concurrent Bronchoscopy Proportion of Cohort Concurrent Esophagoscopy Proportion of Cohort
Hospital case volume Hospital case volume
Low 30.9% Low 36.2%
Medium 27.2% Medium 33.7%
High 0.6% High 4.9%
Health service area (HSA) Health service area (HSA)
1st quintile 9.4% 1st quintile 15.4%
2nd quintile 15.6% 2nd quintile 20.7%
3rd quintile 14.4% 3rd quintile 20.4%
4th quintile 11.2% 4th quintile 16.7%
5th quintile 15.3% 5th quintile 19.5%
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Although it is not possible to determine whether this vari-
ation represents wasteful or inappropriate care, the find-
ing that high rates of concurrent bronchoscopy and
esophagoscopy mainly occur in lower-volume centers is
certainly a matter of concern.
The lower rates of bronchoscopy and esophagoscopy
in high-volume hospitals may be explained by 3 possibil-
ities. First, tertiary care referral centers tend to be high-
volume centers and may consequently treat a large percent-
age of patients who already underwent extensive workup in
other hospitals prior to referral. With sufficiently thorough
documentation from outside sources, head and neck oncol-
ogists at tertiary care centers may be less inclined to dupli-
cate diagnostic procedures such as esophagoscopy and
proceed more quickly to definitive treatment. It was not
possible to determine whether any of the patients in the
high-volume hospitals in our study had been referred from
other centers to verify our hypothesis.
The second possibility is that the variation in bron-
choscopy and esophagoscopy reflects ongoing disagree-
ment about the utility of these diagnostic procedures. It is
commonly accepted that routine UADT endoscopy will
detect asymptomatic tumors in the head and neck, partic-
ularly synchronous lesions.15,16 Clinicians in favor of
symptom-directed endoscopy report that this is more effi-
cient and cost-effective than panendoscopy.17 In contrast,
proponents of panendoscopy argue that the associated
morbidity rate is low and that in patients with primary
HNC, there is a significant possibility of identifying syn-
chronous tumors of the head and neck.18,19 However,
although panendoscopy is still considered the most effec-
tive means of detecting second primary tumors in patients
with HNC, there is no evidence to suggest that patients
with synchronous tumors in the lungs or esophagus have
increased survival rates if the tumors are detected by
screening rather than close follow-up.7 Others have sug-
gested increasing roles for nonsurgical means to either
supplement or replace endoscopy for diagnosing HNC,
including positron emission tomography (PET), CT, or
PET/CT imaging.20,21
Third, it is possible that low-volume surgeons may
simply not be aware of changes in clinical guidelines. Prior
research has demonstrated lower adherence to clinical
guidelines by community-based clinicians compared with
clinicians based at academic or teaching hospitals,
whether surgical or medical,22-25 and community-based
surgical centers tend to be lower-volume than their aca-
demic counterparts.22 However, our study was not
designed to determine adherence to current clinical guide-
lines for HNC diagnosis based on practice setting, and
further research would need to be undertaken to investi-
gate this phenomenon.
This variation in practice may be influenced in part
by a lack of clear clinical guidelines. Specialty-based
guidelines published by the American Head and Neck So-
ciety in 1995 do not recommend routine bronchoscopy
or esophagoscopy for cancers of the nasopharynx, oral cav-
ity, oropharynx, and larynx unless the patient demon-
strates a significantly high risk of a synchronous primary
tumor (ie, alcohol and tobacco abusers in nasopharyngeal
cancer) or if symptoms are present, reserving these modal-
ities for routine use primarily in head and neck metastases
of unknown primary and cancers of the hypopharynx.
These have since been superseded by the NCCN guide-
lines, which are ambiguously worded in regards to opti-
mal UADT endoscopic evaluation. Although the 2008
NCCN guidelines specifically recommended both diag-
nostic bronchoscopy and esophagoscopy for evaluating
occult HNC and cancers of the oropharynx and hypo-
pharynx, the language in the 2012 version is less explicit.
There is no longer a specific endorsement of bronchos-
copy in routine HNC diagnostic workup, whereas esoph-
agoscopy is now specifically suggested only for occult
primary evaluation. This study does not consider the
question of appropriateness of diagnostic bronchoscopy
or esophagoscopy in the context of clinical guideline ad-
herence or the utility of UADT endoscopy in detecting
cancers which would have otherwise gone undiagnosed,
and further prospective research would be necessary to
address these issues.
By defining our primary cohort as patients with
HNC who underwent diagnostic laryngoscopy, we
intended to capture the broadest possible segment of indi-
viduals who would have plausibly undergone concurrent
bronchoscopy and/or esophagoscopy. The SASD does
not contain information on whether these cases of HNC
were new or recurrent, nor did we examine whether
patients were diagnosed with more than one HNC
because we did not intend to evaluate synchronous or
multicentric lesions nor did we plan on stratifying out-
comes by tumor subsite. Stratifying patients by subsite
would have reduced the effective volume of patients in
our study substantially. In addition, this study also was
not designed to capture whether patients underwent diag-
nostic PET or CT imaging modalities, because the SASD
data set is surgical and not specifically intended for analy-
sis of radiographic data. We did discover that esophageal
radiographic studies were only rarely performed, although
it is likely that many of these diagnostic interventions
were performed in nonoperative settings. A different
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database would be necessary to evaluate radiographic
diagnostic volume more fully.
This study has several other limitations that must be
considered. We omitted patient comorbidity in our study
because of the low morbidity associated with UADT en-
doscopy. Although it is possible that a patient with severe
or numerous comorbidities precluding general anesthesia
might elect to undergo less invasive diagnostic procedures,
it would be unlikely that these comorbidities would justify
undergoing only diagnostic laryngoscopy, without other
endoscopic procedures, in the operating room. The SASD
data sets do not contain tumor staging, long-term survival
figures, or other clinical data that would have allowed a
more nuanced examination of patient populations served
within each category of hospital or an assessment of the
appropriateness of these diagnostic procedures. As a
result, we were unable to determine the number of esoph-
ageal or lung cancer cases that were identified as a result of
endoscopy or the number of cases that went undiagnosed
due to lack of endoscopy. Finally, SASD does not have
cost-to-charge ratio data that would eliminate local differ-
ences in price markup and permit a better estimation of
the true financial expenses incurred by hospitals perform-
ing endoscopy.26 Administrative or claims data sets such
as SASD are also subject to systematic or nonsystematic
coding errors and missing data.
CONCLUSIONS
HNC patients undergoing diagnostic laryngoscopy in
low- and medium-volume hospitals are significantly more
likely to also undergo concurrent bronchoscopy or esoph-
agoscopy compared to their counterparts in high-volume
hospitals. Given the persistent controversy over the utility
of routine use of these diagnostic procedures, it is not pos-
sible to say which practice is better, but the extreme varia-
tion found in practice suggests that studies designed to
compare the utility of comprehensive versus selective
diagnostic UADT endoscopy is needed.
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